Fed Sinks Markets
Health Care: Drugs
Sangamo BioSciences Inc. (SGMO: NASDAQ)
$7.93 -0.25 | -3.06%
06/19/13 - 04:00 PM ET
398.41K / 718.10K
Vol / Avg. Vol:8.18 / 8.18
Open / Prev. Close:7.86 - 8.25
Today's Range:4.77 - 11.24
52 Wk Range:36.11%
Performance YTD:TheStreet Rating:
Portfolios with SGMO
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- UserMy Portfolio
- ContributorTechnical Setups for the We...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- UserStock Game
- Contributor10 Biotech Trades for Secon...
- UserEnergy and Biotech
Latest SGMO Headlines from TheStreet
- Cramer's Top Stock Picks: CAT CAG MHR ISS ALNY SGMO KIM 04.04.13 | 06:04 am
- Cramer's 'Mad Money' Recap: Risk vs. Reward 04.03.13 | 08:04 pm
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- 5 Stocks Under $10 Set to Soar 03.28.13 | 01:03 pm
- Sangamo's HIV Gene Therapy Is A Valuation Prop, Nothing More 03.06.13 | 01:03 pm
- 5 Stocks Under $10 Set to Soar 02.28.13 | 01:02 pm
- Biotech Stock Mailbag: Keryx, Sangamo, Threshold and Amarin 01.25.13 | 07:01 am
- The Twitterverse's Biotech Stock Picks for 2013 01.02.13 | 08:01 am
- The Next Big Thing In Biotech: Ligand, BioMarin & Sangamo
11.30.12 | 05:11 am - 5 Technical Trades Under $10 09.04.12 | 03:09 pm
Press Releases for SGMO
- Sangamo BioSciences Receives $6.4 Million Strategic Partnership Award From California Institute For Regenerative Medicine (CIRM) To Develop ZFP Therapeutic® For Beta-thalassemia - PR Newswire 05.24.13 | 07:05 am
- Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases - PR Newswire 05.20.13 | 07:05 am
- Sangamo BioSciences Presents Clinical Data Demonstrating HIV Reservoir Reduction In HIV-Infected Subjects Treated With ZFP Therapeutic®, SB-728-T - PR Newswire 05.15.13 | 10:05 am
- Sangamo BioSciences Announces Presentation At The Bank Of America Merrill Lynch 2013 Health Care Conference - PR Newswire 05.09.13 | 04:05 pm
- Sangamo BioSciences Announces First Quarter 2013 Conference Call And Webcast - PR Newswire 05.01.13 | 04:05 pm
- Sangamo BioSciences Announces Presentation At The Needham Healthcare Conference - PR Newswire 04.24.13 | 04:04 pm
- Sangamo Presents New Clinical Data At CROI 2013 Demonstrating Persistent Immune System Improvements After Treatment With ZFN Therapeutic® SB-728-T - PR Newswire 03.06.13 | 11:03 am
- Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference - PR Newswire 03.05.13 | 04:03 pm
- Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference - PR Newswire 02.27.13 | 04:02 pm
- Sangamo BioSciences Announces Presentations At Upcoming Investor Conferences - PR Newswire 02.07.13 | 04:02 pm
Partner Headlines for SGMO
- 3 Speculative Biotechs Worth Watching - Seeking Alpha 07.08.12 | 08:07 am
- Stocks Choppy; U.S. Manufacturing Data Show Modest Gains, Greece Weighs - NASDAQ 10.03.11 | 04:10 pm
- Mid-Day Update: Stocks Fall as Greece Concerns Outweigh Economic Uptick - NASDAQ 10.03.11 | 04:10 pm
- Sangamo's Phase II Results To Be Announced Monday - Expect Good News - Seeking Alpha 10.02.11 | 07:10 am
- Sangamo BioSciences to Host Conference Call to Discuss Results From Phase 2b Diabetic Neuropathy Trial Monday 8:30am - Benzinga 09.30.11 | 06:09 pm
- Sangamo gene therapy shows promise in reducing HIV - Reuters 09.18.11 | 01:09 pm
- Sangamo Biosciences's Game Changing Technology - Seeking Alpha 04.20.11 | 08:04 am
- Squeeze Ideas: 17 Short Seller Targets for a Watchlist - Seeking Alpha 04.01.11 | 06:04 pm
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- Sangamo HIV drug shown to boost immune cell counts - Reuters 02.28.11 | 08:02 am
